Perspectives on Sex- and Gender-Specific Prediction of New-Onset Atrial Fibrillation by Leveraging Big Data

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 Jul 28

PMID 35898269

Authors

Sven Geurts

Zuolin Lu

Maryam Kavousi

Affiliations

Soon will be listed here.

Abstract

Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, has a large impact on quality of life and is associated with increased risk of hospitalization, morbidity, and mortality. Over the past two decades advances regarding the clinical epidemiology and management of AF have been established. Moreover, sex differences in the prevalence, incidence, prediction, pathophysiology, and prognosis of AF have been identified. Nevertheless, AF remains to be a complex and heterogeneous disorder and a comprehensive sex- and gender-specific approach to predict new-onset AF is lacking. The exponential growth in various sources of big data such as electrocardiograms, electronic health records, and wearable devices, carries the potential to improve AF risk prediction. Leveraging these big data sources by artificial intelligence (AI)-enabled approaches, in particular in a sex- and gender-specific manner, could lead to substantial advancements in AF prediction and ultimately prevention. We highlight the current status, premise, and potential of big data to improve sex- and gender-specific prediction of new-onset AF.

Citing Articles

Electrocardiographic parameters and the risk of new-onset atrial fibrillation in the general population: the Rotterdam Study.

Geurts S, Tilly M, Kors J, Deckers J, Stricker B, de Groot N Europace. 2023; 25(6).

PMID: 37369558 PMC: 10299895. DOI: 10.1093/europace/euad164.

References

Suenari K, Chao T, Liu C, Kihara Y, Chen T, Chen S . Usefulness of HATCH score in the prediction of new-onset atrial fibrillation for Asians. Medicine (Baltimore). 2017; 96(1):e5597. PMC: 5228657. DOI: 10.1097/MD.0000000000005597. View

Kavousi M . Differences in Epidemiology and Risk Factors for Atrial Fibrillation Between Women and Men. Front Cardiovasc Med. 2020; 7:3. PMC: 7025483. DOI: 10.3389/fcvm.2020.00003. View

Ko D, Rahman F, Martins M, Hylek E, Ellinor P, Schnabel R . Atrial fibrillation in women: treatment. Nat Rev Cardiol. 2016; 14(2):113-124. PMC: 5520636. DOI: 10.1038/nrcardio.2016.171. View

Castro H, Garcia-Racines J, Bernal-Norena A . Methodology for the prediction of paroxysmal atrial fibrillation based on heart rate variability feature analysis. Heliyon. 2021; 7(11):e08244. PMC: 8569481. DOI: 10.1016/j.heliyon.2021.e08244. View

Parsi A, Glavin M, Jones E, Byrne D . Prediction of paroxysmal atrial fibrillation using new heart rate variability features. Comput Biol Med. 2021; 133:104367. DOI: 10.1016/j.compbiomed.2021.104367. View

Goldenberg I, Erath J, Russo A, Burch A, Assmus B, Bonderman D . Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator. Heart Rhythm. 2020; 18(3):404-410. DOI: 10.1016/j.hrthm.2020.11.025. View

Belle V, Papantonis I . Principles and Practice of Explainable Machine Learning. Front Big Data. 2021; 4:688969. PMC: 8281957. DOI: 10.3389/fdata.2021.688969. View

Grout R, Hui S, Imler T, El-Azab S, Baker J, Sands G . Development, validation, and proof-of-concept implementation of a two-year risk prediction model for undiagnosed atrial fibrillation using common electronic health data (UNAFIED). BMC Med Inform Decis Mak. 2021; 21(1):112. PMC: 8019173. DOI: 10.1186/s12911-021-01482-1. View

Alonso A, Krijthe B, Aspelund T, Stepas K, Pencina M, Moser C . Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013; 2(2):e000102. PMC: 3647274. DOI: 10.1161/JAHA.112.000102. View

10.

Chugh S, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin E . Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2013; 129(8):837-47. PMC: 4151302. DOI: 10.1161/CIRCULATIONAHA.113.005119. View

11.

Laureanti R, Conte G, Corino V, Osswald S, Conen D, Roten L . Sex-related electrocardiographic differences in patients with different types of atrial fibrillation: Results from the SWISS-AF study. Int J Cardiol. 2020; 307:63-70. DOI: 10.1016/j.ijcard.2019.12.053. View

12.

Staerk L, Wang B, Preis S, Larson M, Lubitz S, Ellinor P . Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 2018; 361:k1453. PMC: 5917175. DOI: 10.1136/bmj.k1453. View

13.

Boon K, Khalil-Hani M, Malarvili M . Paroxysmal atrial fibrillation prediction based on HRV analysis and non-dominated sorting genetic algorithm III. Comput Methods Programs Biomed. 2017; 153:171-184. DOI: 10.1016/j.cmpb.2017.10.012. View

14.

Johnson J, Greaves L, Repta R . Better science with sex and gender: Facilitating the use of a sex and gender-based analysis in health research. Int J Equity Health. 2009; 8:14. PMC: 2689237. DOI: 10.1186/1475-9276-8-14. View

15.

Ebrahimzadeh E, Kalantari M, Joulani M, Shahraki R, Fayaz F, Ahmadi F . Prediction of paroxysmal Atrial Fibrillation: A machine learning based approach using combined feature vector and mixture of expert classification on HRV signal. Comput Methods Programs Biomed. 2018; 165:53-67. DOI: 10.1016/j.cmpb.2018.07.014. View

16.

Banerjee A, Chen S, Fatemifar G, Zeina M, Lumbers R, Mielke J . Machine learning for subtype definition and risk prediction in heart failure, acute coronary syndromes and atrial fibrillation: systematic review of validity and clinical utility. BMC Med. 2021; 19(1):85. PMC: 8022365. DOI: 10.1186/s12916-021-01940-7. View

17.

Lin S, Ikram M . On the relationship of machine learning with causal inference. Eur J Epidemiol. 2019; 35(2):183-185. DOI: 10.1007/s10654-019-00564-9. View

18.

Hill N, Ayoubkhani D, McEwan P, Sugrue D, Farooqui U, Lister S . Predicting atrial fibrillation in primary care using machine learning. PLoS One. 2019; 14(11):e0224582. PMC: 6824570. DOI: 10.1371/journal.pone.0224582. View

19.

Schirmer S, Hohl M, Bohm M . Gender differences in heart failure: paving the way towards personalized medicine?. Eur Heart J. 2010; 31(10):1165-7. DOI: 10.1093/eurheartj/ehq073. View

20.

Doull M, Runnels V, Tudiver S, Boscoe M . Appraising the evidence: applying sex- and gender-based analysis (SGBA) to Cochrane systematic reviews on cardiovascular diseases. J Womens Health (Larchmt). 2010; 19(5):997-1003. DOI: 10.1089/jwh.2009.1626. View